These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8931035)

  • 41. Bone mineral density and biochemical markers of bone turnover in healthy elderly men and women.
    Krall EA; Dawson-Hughes B; Hirst K; Gallagher JC; Sherman SS; Dalsky G
    J Gerontol A Biol Sci Med Sci; 1997 Mar; 52(2):M61-7. PubMed ID: 9060971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the anti-osteoporotic effects of metformin and sitagliptin in postmenopausal diabetic women.
    Hegazy SK
    J Bone Miner Metab; 2015 Mar; 33(2):207-12. PubMed ID: 24633493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discordance between changes in bone mineral density measured at different skeletal sites in perimenopausal women--implications for assessment of bone loss and response to therapy: The Danish Osteoporosis Prevention Study.
    Abrahamsen B; Stilgren LS; Hermann AP; Tofteng CL; Bärenholdt O; Vestergaard P; Brot C; Nielsen SP
    J Bone Miner Res; 2001 Jul; 16(7):1212-9. PubMed ID: 11450696
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationships among the metabolic syndrome, bone mineral density, bone turnover markers, and hyperglycemia.
    Terzi R; Dindar S; Terzi H; Demirtaş Ö
    Metab Syndr Relat Disord; 2015 Mar; 13(2):78-83. PubMed ID: 25470355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of subcutaneous oestradiol implants on biochemical markers of bone turnover and bone mineral density in postmenopausal women.
    Pereda CA; Hannon RA; Naylor KE; Eastell R
    BJOG; 2002 Jul; 109(7):812-20. PubMed ID: 12135219
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: a case control study.
    Atteritano M; Sorbara S; Bagnato G; Miceli G; Sangari D; Morgante S; Visalli E; Bagnato G
    PLoS One; 2013; 8(6):e66991. PubMed ID: 23818972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry.
    Glendenning P; Kent GN; Adler BD; Matz L; Watson I; O'Driscoll GJ; Hurley DM
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):347-55. PubMed ID: 10435061
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.
    Tascioglu F; Colak O; Armagan O; Alatas O; Oner C
    Rheumatol Int; 2005 Nov; 26(1):21-9. PubMed ID: 15688191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biochemical markers of bone turnover reflect femoral bone loss in elderly women.
    Dresner-Pollak R; Parker RA; Poku M; Thompson J; Seibel MJ; Greenspan SL
    Calcif Tissue Int; 1996 Nov; 59(5):328-33. PubMed ID: 8849397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biochemical markers for bone turnover predict risk of vertebral fractures in postmenopausal women over 10 years: the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
    Tamaki J; Iki M; Kadowaki E; Sato Y; Chiba Y; Akiba T; Matsumoto T; Nishino H; Kagamimori S; Kagawa Y; Yoneshima H;
    Osteoporos Int; 2013 Mar; 24(3):887-97. PubMed ID: 22885773
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclical etidronate therapy for prevention of postmenopausal bone loss: a 1-year open-label follow-up study.
    Fogelman I; Herd RJ; Blake GM; Balena R
    Calcif Tissue Int; 2000 May; 66(5):348-54. PubMed ID: 10773104
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
    Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of a Multispecies Probiotic Supplement on Bone Health in Osteopenic Postmenopausal Women: A Randomized, Double-blind, Controlled Trial.
    Jafarnejad S; Djafarian K; Fazeli MR; Yekaninejad MS; Rostamian A; Keshavarz SA
    J Am Coll Nutr; 2017; 36(7):497-506. PubMed ID: 28628374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability.
    Hannon R; Blumsohn A; Naylor K; Eastell R
    J Bone Miner Res; 1998 Jul; 13(7):1124-33. PubMed ID: 9661076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Moderate alcohol intake lowers biochemical markers of bone turnover in postmenopausal women.
    Marrone JA; Maddalozzo GF; Branscum AJ; Hardin K; Cialdella-Kam L; Philbrick KA; Breggia AC; Rosen CJ; Turner RT; Iwaniec UT
    Menopause; 2012 Sep; 19(9):974-9. PubMed ID: 22922514
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables.
    Terzi T; Terzi M; Tander B; Cantürk F; Onar M
    J Clin Neurosci; 2010 Oct; 17(10):1260-4. PubMed ID: 20619660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevention of early postmenopausal bone loss with cyclical etidronate.
    Adami S; Bruni V; Bianchini D; Becorpi A; Lombardi P; Campagnoli C; Ferrari A; Marchesoni T; Balena R
    J Endocrinol Invest; 2000 May; 23(5):310-6. PubMed ID: 10882149
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
    Gallagher JC; Fowler SE; Detter JR; Sherman SS
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endogenous sex steroid, GH and IGF-I levels in normal elderly men: relationships with bone mineral density and markers of bone turnover.
    Gürlek A; Gedik O
    J Endocrinol Invest; 2001 Jun; 24(6):408-14. PubMed ID: 11434664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospective study of bone loss in pre- and post-menopausal women on L-thyroxine therapy for non-toxic goitre.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Astazi P; Caradonna P
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):529-35. PubMed ID: 9425392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.